The Path to Dermatopathology: What to Know Before You Apply
Applying to dermatopathology fellowship stirs a mix of emotions—excitement, uncertainty, maybe even a bit of stress. The process can feel extremely overwhelming because the dermatopathology application process is significantly different from the residency application process. There’s no ERAS. No Match. Just a lot of googling, emailing, and figuring it out as you go.
In this article, we will …
Applying to dermatopathology fellowship stirs a mix of emotions—excitement, uncertainty, maybe even a bit of stress. The process can feel extremely overwhelming because the dermatopathology application process is significantly different from the residency application process. There’s no ERAS. No Match. Just a lot of googling, emailing, and figuring it out as you go.
In this article, we will … Continue reading "The Path to Dermatopathology: What to Know Before You Apply"
Welcome to another installment of our popular “From the JDD Podcast Vault” series! This week, we’re unraveling the fascinating story behind itch management with the episode: From Rags to Itches: The Evolution of Topical and Systemic Options for Pruritus, hosted by the ever-engaging Dr. Adam Friedman.
We all know that urge—“Just scratch it!” But for countless patients, chronic prurit … 
A healthy 50-year-old patient presents with three-month history of progressive hair loss and scalp redness with associated pruritus. On closer scalp examination, there is perifollicular erythema, inflammation, and scaling. There appears to be loss of follicular openings in the erythematous patch. In addition, erythematous and skin-col … 
The June 2025 issue of the Journal of Drugs in Dermatology delivers a diverse and thought-provoking selection of studies that place a spotlight on acne and rosacea while spanning the latest innovations and clinical insights across the dermatology spectrum. This month’s editor’s picks feature new approaches to some of the field’s most common—and challenging—conditions, from acne-induced … 
Use of GLP-1 agonists is becoming increasingly more common in the U.S. According to a 2024 poll, one in eight adults has at least tried this medication class. A brief communication published in the June Journal of Drugs in Dermatology shares concerns that could arise when a patient is concurrently on a GLP-1 agonist and isotretinoin.
I interviewed author Travis W. Blalock, MD, FAAD, FACMS, dire …